Form 4 for EDIT Editas Medicine, Inc.
Accepted 2026-07-29 16:51:02 ET · period of report 2026-07-28 · accession 0001650664-26-000076 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-29 16:51 | 2026-07-28 | EDIT | Burkly Linda | EVP, CSO | S - Sale | $2.67 | -4,928 | 62.4K | -7% | -$13.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-28 | S | D | 4,928 | $2.67 | 62,369 | D | — | — | (F1) Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 24, 2026. The sale does not represent a discretionary trade by the Reporting Person. |